The search engine found new reagents in the following categories.
SARS-CoV-2
NR-58917
|
Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Native Antigen, Clone 65.3.1 (produced in vitro)
SARS-Related Coronavirus 2
|
BEI Level 1
|
November
2023
|
NR-58919
|
Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Native Antigen, Clone 92.1.1 (produced in vitro)
SARS-Related Coronavirus 2
|
BEI Level 1
|
November
2023
|
NR-58914
|
Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Native Antigen, Clone 58.2.2 (produced in vitro)
SARS-Related Coronavirus 2
|
BEI Level 1
|
November
2023
|
NR-58912
|
Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Native Antigen, Clone 34.2.2 (produced in vitro)
SARS-Related Coronavirus 2
|
BEI Level 1
|
November
2023
|
NR-58913
|
Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Native Antigen, Clone 57.1.2 (produced in vitro)
SARS-Related Coronavirus 2
|
BEI Level 1
|
November
2023
|
NR-58916
|
Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Native Antigen, Clone 62.1.1 (produced in vitro)
SARS-Related Coronavirus 2
|
BEI Level 1
|
November
2023
|
NR-58918
|
Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Native Antigen, Clone 82.6.2 (produced in vitro)
SARS-Related Coronavirus 2
|
BEI Level 1
|
November
2023
|
NR-59501
|
SARS-Related Coronavirus 2
Isolate hCoV-19/USA/MD-HP47865/2023 (Lineage XBB.2.3; Omicron Variant)
|
BEI Level 3
|
November
2023
|
NR-59638
|
SARS-Related Coronavirus 2
SARS-Related Coronavirus 2, Isolate hCoV-19/USA/MI-UM-10052670540/2023 (Lineage BA.2.86) in VTA Cells
|
BEI Level 3
|
November
2023
|
NR-59502
|
SARS-Related Coronavirus 2
Isolate hCoV-19/USA/MD-HP46933/2023 (Lineage EG.1.2; Omicron Variant)
|
BEI Level 3
|
November
2023
|
NR-59500
|
SARS-Related Coronavirus 2
Isolate hCoV-19/USA/MD-HP47866/2023 (Lineage GJ.2; Deposited as XBB.2.3.3)
|
BEI Level 3
|
November
2023
|
NR-59442
|
SARS-Related Coronavirus 2
Isolate hCoV-19/USA/CA-Stanford-139_S23/2023 (Lineage XBB.1.16; Omicron Variant)
|
BEI Level 3
|
October
2023
|
NR-56480
|
Spike S1 Glycoprotein from SARS-Related Coronavirus 2, B.1.1.529 (Omicron) with C-Terminal Histidine Tag, Recombinant from HEK293 Cells
SARS-Related Coronavirus 2
|
BEI Level 1
|
September
2023
|
NR-54975
|
SARS Coronavirus
Vector pαH Containing the SARS Coronavirus, Recombinant Spike Ectodomain Gene
|
BEI Level 1
|
September
2023
|
NR-59441
|
SARS-Related Coronavirus 2
Isolate hCoV-19/USA/CA-Stanford-139_S35/2023 (Lineage XBB.1.9)
|
BEI Level 3
|
September
2023
|
NR-59503
|
SARS-Related Coronavirus 2
Isolate hCoV-19/USA/MD-HP47946/2023 (Lineage EG.5.1; Omicron Variant)
|
BEI Level 3
|
August
2023
|
NR-58714
|
HEK293T Cells (ACE2-30F-PLP2), SARS-CoV-2 Luminescent Reporter, Clone B7
|
BEI Level 2
|
August
2023
|
NR-54976
|
Human Coronavirus
Vector pαH Containing the Human Coronavirus, NL63 Recombinant Spike Ectodomain Gene
|
BEI Level 1
|
August
2023
|
NRH-28563
|
Pooled Human Serum Sample, Moderna Vaccine/Moderna Booster (Omicron)
|
BEI Level 2
|
August
2023
|
NR-56785
|
Monoclonal Anti-SARS-Related Coronavirus 2 Full-Length Spike Protein, Clone 5AB3 (produced in vitro)
SARS-Related Coronavirus
|
BEI Level 1
|
August
2023
|